XML 33 R22.htm IDEA: XBRL DOCUMENT v3.26.3
Organization - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 14, 2026
Oct. 13, 2026
Jul. 22, 2026
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Jul. 06, 2026
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2025
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Cash, cash equivalents and restricted cash       $ 615 $ 615 $ 1,938     $ 1,385   $ 1,091
Accumulated deficit       $ 927,352 $ 927,352       $ 924,622    
Common stock, shares outstanding       3,324,697 3,324,697       2,349,480    
Common stock, shares authorized       50,000,000 50,000,000       50,000,000    
Minimum required amount of stockholder equity                 $ 2,500    
Total stockholders' equity       $ 971 $ 971 2,803   $ 652 2,153 $ 3,661 2,063
Minimum market value     $ 5,000                
Aggregate offering price     $ 5,000 $ 916 $ 916 $ 998          
Velaris Therapeutics Inc [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Acquisition date   Oct. 13, 2026                  
2020 Equity Incentive Plan [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Common stock reserved for future issuance             1,000,000        
Common stock, shares authorized       484,156 484,156            
Series B Preferred Stock [Member] | Velaris Therapeutics Inc [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Preferred stock, shares issued   105,286                  
Preferred stock, par value   $ 0.001                  
Series C Preferred Stock [Member] | Velaris Therapeutics Inc [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Preferred stock, shares issued   33,054                  
Preferred stock, par value   $ 0.001                  
Number of preferred stock converted into common stock   1,000                  
Series C Preferred Stock [Member] | Private Placement [Member] | Velaris Therapeutics Inc [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Common stock issuance 243,063 243,063                  
Price per share   $ 1,435.7                  
Gross proceeds from issuance of preferred stock in connection with private placement $ 350,000 $ 350,000                  
Series C Preferred Stock [Member] | Private Placement [Member] | Fairmount Healthcare Fund II L.P [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Waiver of cash-settlement in shares 6,268                    
Waiver of cash-settlement $ 9,000                    
Series B And Series C Non Voting Convertible Preferred Stock [Member] | Velaris Therapeutics Inc [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Number of preferred stock converted into common stock   1,000                  
Common Stock [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Common stock, shares outstanding       3,324,697 3,324,697            
Common stock reserved for future issuance       325,852 325,852            
Common stock issuance       380,469 380,469 338,725          
Total stockholders' equity       $ 3 $ 3 $ 2   $ 2 $ 2 $ 2 $ 2
Aggregate offering price       $ 1 $ 1            
Common Stock [Member] | Private Placement [Member] | Velaris Therapeutics Inc [Member] | Subsequent Event [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Common stock issuance 687,789 687,789                  
Price per share   $ 1.4357                  
Series A - 1 Preferred Stock [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Common stock, shares outstanding       500 500            
Series A - 2 Preferred Stock [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Common stock, shares outstanding       850 850